NYSEARCA:IBRN iShares Neuroscience and Healthcare ETF (IBRN) Price, Holdings, & News → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free IBRN Stock Alerts $23.17 +0.38 (+1.67%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$23.17▼$23.1750-Day Range$22.69▼$26.5752-Week Range$19.08▼$26.90Volume18 shsAverage Volume729 shsMarket Capitalization$3.48 millionAssets Under Management$3.42 millionDividend Yield0.06%Net Expense Ratio0.47% Stock AnalysisStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Get iShares Neuroscience and Healthcare ETF alerts: Email Address About iShares Neuroscience and Healthcare ETFThe iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.Read More IBRN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBRN ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive IBRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Neuroscience and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares Neuroscience and Healthcare ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IBRN Inception Date8/24/2022 Fund ManagerJennifer Hsui, Greg Savage, Paul Whitehead, Amy Whitelaw WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE FactSet Global Neuro Biopharma and MedTech Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings63 Fund Statistics Assets Under Management$3.42 million Average Daily Volume$0.00 Discount/Premium-0.02% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerFlow Traders Miscellaneous Outstanding Shares150,000Beta1.05 Creation Unit50,000 Creation Fee$350.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 iShares Neuroscience and Healthcare ETF ExpensesTypeIBRNTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.47%0.57%0.54%0.50%0.51%Other Expenses0.00%0.72%0.54%0.64%0.58%Total Expense0.47%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.76%-0.55%-0.68%-0.57%Net Expense0.47%0.59%0.60%0.58%0.58% iShares Neuroscience and Healthcare ETF (IBRN) Holdings & ExposureTop 10 IBRN HoldingsCerevel Therapeutics(NASDAQ:CERE)Holding Weight: 4.92%Neurocrine Biosciences(NASDAQ:NBIX)Holding Weight: 4.84%Intra-Cellular Therapies(NASDAQ:ITCI)Holding Weight: 4.83%Axonics(NASDAQ:AXNX)Holding Weight: 4.74%argenx(NASDAQ:ARGX)Holding Weight: 4.37%Sarepta Therapeutics(NASDAQ:SRPT)Holding Weight: 4.34%Integra LifeSciences(NASDAQ:IART)Holding Weight: 4.21%Biogen(NASDAQ:BIIB)Holding Weight: 4.13%Xenon Pharmaceuticals(NASDAQ:XENE)Holding Weight: 4.12%Biohaven(NYSE:BHVN)Holding Weight: 4.08%IBRN Sector ExposureIBRN Industry ExposureFull Holdings Details Similar ETFsDirexion Daily Electric and Autonomous Vehicles Bull 2X SharesNYSEARCA:EVAVGlobal X Interest Rate Volatility & Inflation Hedge ETFNYSEARCA:IRVHStockSnips AI Powered Sentiment US All Cap ETFNYSEARCA:NEWZSPDR Kensho Final Frontiers ETFNYSEARCA:XKFFHorizon Kinetics Energy and Remediation ETFNYSEARCA:NVIR IBRN ETF - Frequently Asked Questions How have IBRN shares performed in 2024? iShares Neuroscience and Healthcare ETF's stock was trading at $26.23 on January 1st, 2024. Since then, IBRN stock has decreased by 11.7% and is now trading at $23.1737. View the best growth stocks for 2024 here. What does IBRN invest in? iShares Neuroscience and Healthcare ETF is a equity fund issued by iShares. IBRN focuses on theme investments and follows the NYSE FactSet Global Neuro Biopharma and MedTech Index. The fund's investments total to approximately $3.42 million assets under management. What stocks does iShares Neuroscience and Healthcare ETF hold? IBRN invests in 63 holdings. Some of the stocks in their portfolio include Cerevel Therapeutics (CERE), Neurocrine Biosciences (NBIX), Intra-Cellular Therapies (ITCI), Axonics (AXNX), argenx (ARGX), Sarepta Therapeutics (SRPT), Integra LifeSciences (IART), Biogen (BIIB), Xenon Pharmaceuticals (XENE) and Biohaven (BHVN). What is the management fee for iShares Neuroscience and Healthcare ETF? iShares Neuroscience and Healthcare ETF's management fee is 0.47% and has no other recorded expenses or fee waivers. The net expense ratio for IBRN is 0.47%. How do I buy shares of iShares Neuroscience and Healthcare ETF? Shares of IBRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:IBRN) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
